PALLA, ROBERTA

PALLA, ROBERTA  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 99 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency 2022 Roberta PallaFlora Peyvandi + Article (author) -
Hemostatic alterations in COVID-19 2021 Peyvandi, FloraArtoni, AndreaNovembrino, CristinaAliberti, StefanoGualtierotti, RobertaRossi, FedericaPalla, RobertaGrasselli, GiacomoBlasi, FrancescoTripodi, Armando + Article (author) -
Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia A 2021 Hassan S.Palla R.Valsecchi C.Garagiola I.Karimi M.Mannucci P. M.Peyvandi F. + Article (author) -
No changes of parameters nor coagulation activation in healthy subjects vaccinated for {SARS}-Cov-2 2021 Flora PeyvandiErica ScalambrinoMarigrazia ClericiRoberta PallaRoberta Gualtierotti + Article (author) -
Lombardy Network for the Study and Treatment of Patients Undergoing Apheresis 2020 I. ManciniP. AgostiR. PallaF. Peyvandi + Book Part (author) -
An international registry of patients with plasminogen deficiency (HISTORY) 2020 Menegatti, MarziaPalla, RobertaPeyvandi, Flora + Article (author) -
IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia A 2020 Peyvandi F.Miri S.Bucciarelli P.Valsecchi C.Palla R.Mannucci P. M. + Article (author) -
Lombardy network for the study and treatment of patients undergoing apheresis 2020 I. ManciniP. AgostiR. PallaF. Peyvandi + Article (author) -
Clinical and Laboratory Features of Patients with Acquired Thrombotic Thrombocytopenic Purpura: Fourteen Years of the Milan TTP Registry 2019 Mancini I.Palla R.Artoni A.Valsecchi C.Payvandi F. + Article (author) -
Role of the factor VIII-binding capacity of endogenous von Willebrand factor on the development of factor VIII inhibitors in patients with severe hemophilia A 2019 Palla, RobertaPeyvandi, Flora + Article (author) -
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" 2019 Peyvandi, FloraPalla, Roberta + Article (author) -
Choices of factor VIII products in previously untreated patients with haemophilia A: A global survey 2018 Payvandi, F.Palla, R.Franchi, C.Mannucci, P. M. + Article (author) -
High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis 2018 Peyvandi, FloraPalla, Roberta + Article (author) -
Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis 2018 Peyvandi, F.Garagiola, I.Palla, R.Karimi, M. + Article (author) -
Risk factors for inhibitor development in severe hemophilia A 2018 Garagiola, IsabellaPalla, RobertaPeyvandi, Flora Article (author) -
Potential misdiagnosis of dysfibrinogenaemia: Data from multicentre studies amongst UK NEQAS and PRO-RBDD project laboratories 2017 Menegatti, M.Palla, R.Peyvandi, F. + Article (author) -
The Influence of F8 Mutation and Thrombophilic Genetic Markers on Bleeding Phenotype of Patients Affected with Severe Hemophilia A in the SIPPET Cohort 2017 S. SpenaR. PallaI. GaragiolaM. KarimiM. E. MancusoF. Peyvandi + Article (author) -
Detection of Factor XIII deficiency: data from multicentre exercises amongst UK NEQAS and PRO-RBDD project laboratories 2017 Menegatti, M.Palla, R.Peyvandi, F. + Article (author) -
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A 2017 Valsecchi, CarlaGaragiola, IsabellaPalla, RobertaPeyvandi, Flora + Article (author) -
Minimal factor XIII activity level to prevent major spontaneous bleeds : reply 2017 Menegatti, M.Palla, R.Bucciarelli, P.Peyvandi, F. Article (author) -